MedPath

The effect of Zinc and Selenium co-supplementation in T2D patients

Phase 2
Conditions
Type 2 Diabetes.
Diabetes mellitus due to underlying condition
Registration Number
IRCT20190407043194N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Type 2 Diabetes Melitus
7< HA1c < 9
18.5 < BMI < 30
18 < Age < 65

Exclusion Criteria

Zinc and Selenium consumption in last 3 month
Diabetes complications
autoimmune disorders
cancer
participating in any other studies
pregnancy
Lactating
Smoking

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hemoglobin A1c. Timepoint: Before and after study. Method of measurement: Laboratory test.;FBS. Timepoint: Before and after of intervention. Method of measurement: Laboratory test.;Insulin. Timepoint: Before and after intervention. Method of measurement: Laboratory test.;Interleukin 1 beta. Timepoint: Before and after intervention. Method of measurement: Laboratory test.;Superoxide Dismutase. Timepoint: Before and after intervention. Method of measurement: Laboratory test.;Glutathione peroxidase. Timepoint: Before and after intervention. Method of measurement: Laboratory test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath